Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine

被引:171
作者
Song, YC
Kesuma, D
Wang, H
Deng, Y
Duan, J
Wang, JH
Qi, RZ
机构
[1] Inst Mol & Cell Biol, Singapore 117609, Singapore
[2] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China
[3] China Pharmaceut Univ, Nanjing, Peoples R China
关键词
cyclin-dependent kinase; harmine; beta-carboline alkaloid; competitive inhibitor; cell cycle; cell proliferation;
D O I
10.1016/j.bbrc.2004.03.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs. In the present study. harmine was identified from a collection of herbal Compounds to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles. It displayed little effect on other serine/threonine and tyrosine kinases tested. The CDK inhibition by harmine is competitive with ATP-Mg2+, Suggesting that it binds to the ATPMg(2-)-binding pocket of CDKs. In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts. Further. harmine was found to block DNA replication in the carcinoma cells. Taken together, harmine is a selective inhibitor of CDKs and cell proliferation. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 24 条
  • [1] CHENG HC, 1992, J BIOL CHEM, V267, P9248
  • [2] Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
    Cruz, JC
    Tseng, HC
    Goldman, JA
    Shih, H
    Tsai, LH
    [J]. NEURON, 2003, 40 (03) : 471 - 483
  • [3] GENOTOXIC POTENTIAL OF BETA-CARBOLINES - A REVIEW
    DEMEESTER, C
    [J]. MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY, 1995, 339 (03): : 139 - 153
  • [4] A decade of CDK5
    Dhavan, R
    Tsai, LH
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) : 749 - 759
  • [5] CDK INHIBITORS - ON THE THRESHOLD OF CHECKPOINTS AND DEVELOPMENT
    ELLEDGE, SJ
    HARPER, JW
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (06) : 847 - 852
  • [6] FERNANDEZ DA, 1994, J PHARM PHARMACOL, V46, P809
  • [7] Effects of beta- and gamma-carboline derivatives on DNA topoisomerase activities
    Funayama, Y
    Nishio, K
    Wakabayashi, K
    Nagao, M
    Shimoi, K
    Ohira, T
    Hasegawa, S
    Saijo, N
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1996, 349 (02) : 183 - 191
  • [8] CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE
    HUNTER, T
    PINES, J
    [J]. CELL, 1994, 79 (04) : 573 - 582
  • [9] Antitumor agents 201.: Cytotoxicity of harmine and β-carboline analogs
    Ishida, J
    Wang, HK
    Bastow, KF
    Hu, CQ
    Lee, KH
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (23) : 3319 - 3324
  • [10] Inhibition of monoamine oxidase A by beta-carboline derivatives
    Kim, H
    Sablin, SO
    Ramsay, RR
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 337 (01) : 137 - 142